[Cite as http://purl.org/au-research/grants/nhmrc/632876]
Prof Lars Ittner
Prof Michael Kassiou
Brief description Alzheimer's disease (AD) is the most prevalent dementia, characterized by progressive loss of memory. An estimated 230,000 Australians currently suffer from AD, causing a huge impact on their families and carers, as well as on national finances. The present therapies are very limited, and there is no cure. Thus, there is a need for novel treatment strategies. We have developed novel drugs that represent an innovative approach to the treatment of AD.
Funding Amount $AUD 629,260.47
Funding Scheme NHMRC Project Grants
Standard Project Grant